Using Fat to Turbo-Charge Intracellular Parasite Growth  by McConville, Malcolm J.
Cell Host & Microbe
PreviewsIntestinal pathogens are well known to
exploit the host inflammatory response or
host-derived metabolic byproducts to
outcompete other microbes and estab-
lish colonization. Here, Ferreyra et al.
(2014) and Curtis et al. (2014) both found
that a commensal-derived metabolite,
succinate, can also directly benefit
diverse pathogens belonging to the
Firmicutes (C. difficile) and the Proteo-
bacteria (EHEC and C. rodentium) phyla
(Figure 1). Thus, although the commensal
microbiota often plays a fundamental
role in colonization resistance against
invading pathogens, enteric pathogens
also have evolved different strategies to
exploit metabolic intermediates available
in the inflamed gut for their own advan-
tage (Keeney and Finlay, 2011). Together,
this work represents valuable insight
into the function of microbiota-derivedmetabolites, which can guide the
development of approaches to atten-
uate pathogen virulence or colonization
by modulating the intestinal metabolic
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Early during infection, the malaria parasite invades liver cells and undergoes robust replication, generating
thousands of new parasites within days. In this issue of Cell Host & Microbe, Itoe et al. (2014) show that para-
site replication in the liver depends on the synthesis of host bulk phospholipids, which are incorporated into
the expanding parasite and surrounding vacuolar membranes.Many microbial pathogens have evolved
strategies for surviving and replicating
within host cells. While an intracellular
niche offers some sanctuary from the
host immune system, intracellular patho-
gens face the challenge of scavenging
all of their essential nutrients and carbon
sources from the host cell. Many patho-
gens achieve balanced growth within their
intracellular niche by greatly reducing
their overall growth rate. However, a few
pathogens have evolved strategies for
commandeering host nutrients and meta-
bolic precursors in a way that allows high
growth rates within their respective hostcells. A spectacular example of this
is the liver stage of the malaria parasite
(Prudeˆncio et al., 2006). Infection of the
liver by this parasite occurs immediately
after injection of Plasmodium sporozoite
stages into the skin of the mammalian
host by themosquito vector and is an obli-
gate step in the development of clinical
infection. Following invasion of a liver he-
patocyte, the parasite is surrounded by
a vacuolar membrane, generating an
intracellular compartment in which the
parasite undergoes a burst of nuclear
replication and daughter cell formation.
In the case of the human malaria parasite,Plasmodium falciparum, infection of a
single hepatocyte gives rise to 10,000–
30,000 new parasites (merozoites) over 5
to 6 days. These parasite progeny are
released from their vacuolar compart-
ment and finally from their host cell to
initiate cycles of infection in red blood
cells leading to the symptoms associated
with malaria. The rate of P. falciparum
replication in hepatocytes is almost
without precedent in eukaryotic biology
and greatly exceeds the replication of
bloodstream parasite stages. There is
obvious interest in understanding how
intrahepatic Plasmodium stages achieveecember 10, 2014 ª2014 Elsevier Inc. 705
Figure 1. Salvage of Different Host Lipids by the Malaria Parasite
Replication of the parasite liver stages is dependent on hepatocyte PC synthe-
sis via the Kennedy pathway (using choline and the enzyme CTa) or methyl-
ation of phosphatidylethanolamine ([PE], catalyzed by PEMT). Intracellular
parasites take up a variety of host lipids, including SM (synthesized from PC)
via contact points between the PVM and various host organelles. These
include endocytic/lysosomal vesicles containing host lipoproteins (LDL) rich
in PC as well as neutral lipids such as triacylglycerol (TAG) and cholesterol.
Lipid uptake may supplement parasite pathways of de novo phospholipid
biosynthesis (only PC shown) and/or contribute to the integrity of the PVM.
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Previewsthis feat, as therapeutic
disruption of liver stage
development would prevent
the development of clinical
disease. While there is evi-
dence that these stages are
metabolically more active
(Yu et al., 2008; Vaughan
et al., 2009; Coppens, 2013),
the extent to which they
depend upon the host cell
for complex cellular building
blocks has not been
investigated.
This question has now
been addressed by Itoe et al.
(2014). This group initially
cataloged the levels of the
major membrane lipids of
liver hepatocytes harboring
the murine malaria parasite
P. berghei and found that in-
fected cells displayed partic-
ularly high levels of the bulk
phospholipid phosphatidyl-
choline (PC). Hepatocytes
have a high capacity to syn-
thesize PC, so Itoe et al.
(2014) investigated whethergenetic knockdown of key enzymes
involved in PC synthesis would impact
parasite growth in these cells. Remark-
ably, selective knockdown of enzymes
involved in the biosynthesis of PC from
choline or the conversion of other phos-
pholipids to PC (CTa and PEMT, respec-
tively) both resulted in reduced parasite
growth commensurate with the contribu-
tion that each pathway makes to host
PC biosynthesis (Figure 1). The require-
ment for host PC biosynthesis was
confirmed with the finding that mice with
defects in one or both major pathways of
PC synthesis (by combining knockdown
of PEMT with dietary removal of choline)
had lower parasite loads. To demonstrate
that the malaria parasite acquires PC
directly from the host cell, Itoe et al.
(2014) developed a neat in situ fluorescent
labeling technique that allowed the up-
take of newly synthesized PC by the para-
site to be tracked. The scavenged host
PC was distributed in all parasite-induced
membranes, including the parasite vacu-
olar membrane (PVM) and associated
tubular membrane network surrounding
the parasite, as well as the plasma
membrane of the growing parasite and
newly formed daughter merozoites.706 Cell Host & Microbe 16, December 10, 20Finally, inhibition of host PC biosynthesis
was associated with defective trafficking
of PVM-resident proteins, previously
shown to be essential for intra-hepatocyte
growth, highlighting one process that is
dependent on PC salvage.
While these findings provide compel-
ling evidence that the prodigious growth
rate of parasite liver stages is dependent
on the acquisition of host PC, the reason
why PC specifically is needed is unclear.
The simplest explanation is that the
parasite is unable to synthesize enough
PC, the most abundant phospholipid in
membranes, to sustain the necessary
expansion of parasite and vacuolar mem-
branes during this explosive growth
phase. There may be a strong selection
pressure to decrease the expression
of parasite enzymes whose function can
be bypassed by salvage pathways, allow-
ing the redirection of the finite protein
translation machinery into the synthesis
of other metabolic pathways that are
critical for growth. In this context, it is
possible to view PC salvage as a mecha-
nism to increase metabolic efficiency and
facilitate maximum growth. It is notable
that hepatocytes have particularly high
rates of lipid biosynthesis, and the liver14 ª2014 Elsevier Inc.could be one of the few tis-
sues in mammals capable of
sustaining such high rates of
replication by these para-
sites. A second explanation
for Plasmodium dependency
on PC uptake is that host PC
is needed to maintain a spe-
cific lipid composition in the
PVM and connected tubular
network. Infected hepato-
cytes also accumulate neutral
lipids and cholesterol esters
(Labaied et al., 2011; Itoe
et al., 2014) that could perturb
the bilayer-forming properties
of the PVM, upon which the
parasite is completely depen-
dent for uptake of other
nutrients. In this context, the
uptake of host PC could
enhance bilayer formation
and stabilize the PVM. A third
and related explanation is
that synthesis of host PC
is required for the synthesis
of other lipids, such as sphin-
gomyelin, that could also
regulate the physicochemicalproperties of the PVM (Coppens, 2013)
(Figure 1).
How host PC is transferred to the
different parasite membranes also re-
mains to be addressed. The biosynthesis
of PC in hepatocytes is complex and
can occur in the endoplasmic reticulum,
mitochondria, and the Golgi apparatus,
with subsequent transport to other organ-
elles and the plasma membrane (Fagone
and Jackowski, 2013). The PVM that sur-
rounds the liver stage parasites is highly
dynamic and can produce tubular exten-
sions that come in close contact with
different host organelles, including com-
partments in the endolysosomal system
and the mitochondria (Thieleke-Matos
et al., 2014; Gru¨tzke et al., 2014) (Figure 1).
The PVM contains a number of parasite
proteins that may interact with host pro-
teins involved in lipid transport proteins,
such as the liver fatty acid-binding pro-
tein, which could facilitate the transfer of
complex lipids between host organelles
and PVM junctions.
The Itoe et al. (2014) study highlights
the intimate metabolic interchange that
defines many host-microbe interactions,
and possibly also new therapeutic targets.
While the enzymes involved in hepatocyte
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be drug targets, due to the high level of
redundancy that characterizes different
pathways of de novo biosynthesis, it is
possible that proteins involved in lipid
exchange and transport across the PVM
and parasite membranes are potential
targets. It will be important to confirm
that human-infective species, such as
P. falciparum, P. vivax, and P. ovale, are
also dependent on PC uptake. Each of
these species exhibits subtle differences
in the time they take to develop in the liver
(e.g., 2 versus 7 days for P. berghei and
P. falciparum, respectively) and the final
parasite burdens reached. Significant dif-
ferences may also occur in the metabolic
activity of murine and human liver cells, all
of which could lead to species-specific dif-
ferences in metabolic demands. Another
intriguing possibility is that a decrease in
hepatocyte PC biosynthesis, possibly asa result of choline deficiency, could trigger
latency in some Plasmodium species.
Latency is thought to be associated with
the appearance ofmetabolically quiescent
liver stages and is a distinctive feature of
human infective P. vivax and P. ovale, re-
sulting in nonsymptomatic infections that
can reactivate longafter the initial infection.
Overall, these studies highlight the com-
plex metabolic interactions that underpin
all host-pathogen interactions and the
need to study themetabolismof both part-
ners together.REFERENCES
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Plant effector-triggered immunity is a robust cellular defense response activated by a family of intracellular
receptors. In this issue of Cell Host &Microbe, Wang et al. (2014) show that receptor-activated defense path-
ways utilize several core cell-cycle regulatory components to induce resistance and programmed cell death
against pathogens.Individual plant andmammalian cells have
the innate capacity to recognize interfer-
ence by pathogens and activate disease
resistance pathways. This provides a
crucial early defense mechanism against
infectiousmicrobesand isbroadly referred
to as innate immunity. Without innate
immunity, organisms rapidly succumb to
disease. On the flip side, misregulation
of cellular defenses can lead to autoimmu-
nity with potentially catastrophic conse-
quences for general health and growth
of the host. To enforce tight control,
structurally and functionally related nucle-otide-binding/leucine-rich-repeat recep-
tors (NLRs) have evolved independently
in each kingdom as ligand-dependent
molecular switches that sense pathogen-
driven perturbations in different parts of
thecell (Maekawaetal., 2011).NLRactiva-
tion mobilizes host antimicrobial defenses
and often induces programmed cell death
(PCD). Additional components of innate
immune signaling pathways have been
characterized in both systems, but the
processes by which activated NLRs con-
nectmolecularly to downstreampathways
to elicit timely and effective resistanceremain unclear (Maekawa et al., 2011;
Griebel et al., 2014). Also, operational
relationships between host defense and
cell death programs have not been fully
resolved. In plants, individual NLRs inter-
cept the activities of specific pathogen
effectors (virulence factors) that are deliv-
ered into host cells to disable basal
resistance pathways. Thus, recognition
by NLRs turns effector manipulation of
basal defenses into effector-triggered im-
munity (ETI).
The study by Wang et al. in this issue of
Cell Host & Microbe (Wang et al., 2014) isecember 10, 2014 ª2014 Elsevier Inc. 707
